Quinoline derivatives

US11572357B2 · kind B2 · utility

Assignee

• Bayer Animal Health GmbH · DE

Inventors

• Walter Hubsch · Wuppertal, DE
• Nils Griebenow · Milford, US
• Hans-Georg Schwarz · Dorsten, DE
• Daniel KULKE · Leverkusen, DE
• Claudia Böhm · Hannover, DE
• Kirsten BÖRNGEN · Neunburg vorm Wald, DE
• Bernd Alig · Rübhausen, DE
• Wei Zhuang · Monheim, DE
• Iring HEISLER · Düsseldorf, DE
• Thomas ILG · Monheim, DE
• Johannes Köbberling · Neuss, DE
• Adeline Köhler · Langenfeld, DE
• Niels Lindner · Wuppertal, DE
• Ulrich Görgens · Ratingen, DE
• Claudia WELZ · Goldkronach, DE
• Maike Hink · Markgröningen, DE

Key dates

• Filing date: May 7, 2019
• Grant date: Feb 7, 2023
• Expiry date: Jul 28, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D405/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention covers new quinoline compounds of general formula (I), in which A, R1, R2, R3, R4, R5, R6, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.